-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK - DEAL INCLUDES PRODUCTS USED TO TREAT MORE THAN 40 MILLION PATIENTS IN THE U.S. WHO SUFFER FROM RESPIRATORY CONDITIONS SUCH AS ASTHMA AND COPD

Reuters·12/19/2025 20:09:20

Please log in to view news